Cadence Capital Management’s CareDx CDNA Stock Holding History

Cadence Capital Management’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-67,157	Closed	-$2.42M	–	424
2019 Q2	$2.42M	Sell	67,157 -2,246	-3%	-$71.9K	0.24%	127
2019 Q1	$2.19M	Sell	69,403 -13,879	-17%	-$404K	0.2%	156
2018 Q4	$2.09M	Buy	83,282 +6,447	+8%	+$166K	0.21%	147
2018 Q3	$2.22M	Buy	+76,835	New	+$1.44M	0.12%	235

Other funds holding CDNA

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Cadence Capital Management's CDNA Position: Q3 2019 in Review

Cadence Capital Management sold out of CareDx (CDNA) in Q3 2019, closing a stake of 67,157 shares — an estimated $2.42M sold.

Cadence Capital Management first reported a position in CDNA in Q3 2018 and held it in 4 quarters. The position peaked at $2.42M in Q2 2019. 174 funds tracked by Wall St. Rank hold CDNA as of Q3 2019.

Cadence Capital Management reported no remaining CareDx position as of Q3 2019 after selling out during the quarter.
Cadence Capital Management sold 67,157 CareDx shares in Q3 2019, an estimated $2.42M.
Cadence Capital Management first reported a position in CareDx in Q3 2018 and held it in 4 quarters.
Cadence Capital Management's CareDx position peaked at $2.42M in Q2 2019.
174 funds tracked by Wall St. Rank held CareDx as of Q3 2019.

Based on Cadence Capital Management's 13F filing for Q3 2019, filed 29 Oct 2019.